Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections in children under two years old, resulting in significant morbidity and a heavy economic burden on healthcare ...

Shionogi’s respiratory syncytial virus (RSV) antiviral for adults has proven its ability to reduce viral load in a phase 2 ...

The CDC monitors RSV through the Respiratory Syncytial Virus Hospitalization Surveillance Network (RSV-NET), which comprises 161 counties and county-equivalents in 13 states. The network ...

Here is what to know about the virus, which transmits like other respiratory diseases such as flu and COVID-19. Human metapneumovirus is a respiratory virus that causes flu or cold-like symptoms.

It’s what’s being called a “Quad-demic,” with cases on the rise for COVID-19, Respiratory syncytial virus (RSV), Influenza, ...

The 30-day risks of hospitalization were 17.5%, 15.9%, and 14.4% for COVID, influenza, and RSV, respectively, during the 2022 ...

Respiratory syncytial virus (RSV) is a common viral infection that may lead to serious complications in certain groups. Since 2023, vaccines are now available and are highly recommended ...

also known as respiratory syncytial virus. Like last year, Louisiana's flu case numbers are among the worst in the U.S. Presley Bo Tyler is a reporter for the Louisiana Deep South Connect Team for ...